HomeCompareHGITX vs JNJ

HGITX vs JNJ: Dividend Comparison 2026

HGITX yields 12.16% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 HGITX wins by $24.6K in total portfolio value
10 years
HGITX
HGITX
● Live price
12.16%
Share price
$52.44
Annual div
$6.38
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$44.6K
Annual income
$2,597.67
Full HGITX calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — HGITX vs JNJ

📍 HGITX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodHGITXJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, HGITX + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
HGITX pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HGITX
Annual income on $10K today (after 15% tax)
$1,033.98/yr
After 10yr DRIP, annual income (after tax)
$2,208.02/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, HGITX beats the other by $1,504.41/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HGITX + JNJ for your $10,000?

HGITX: 50%JNJ: 50%
100% JNJ50/50100% HGITX
Portfolio after 10yr
$32.3K
Annual income
$1,712.73/yr
Blended yield
5.30%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

HGITX
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HGITX buys
0
JNJ buys
0
No recent congressional trades found for HGITX or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricHGITXJNJ
Forward yield12.16%3.36%
Annual dividend / share$6.38$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$44.6K$20.0K
Annual income after 10y$2,597.67$827.78
Total dividends collected$18.9K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: HGITX vs JNJ ($10,000, DRIP)

YearHGITX PortfolioHGITX Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,916$1,216.45$10,676$355.77+$1.2KHGITX
2$14,105$1,354.74$11,407$389.39+$2.7KHGITX
3$16,591$1,498.68$12,198$426.53+$4.4KHGITX
4$19,400$1,647.50$13,056$467.62+$6.3KHGITX
5$22,559$1,800.39$13,987$513.12+$8.6KHGITX
6$26,094$1,956.54$14,998$563.56+$11.1KHGITX
7$30,036$2,115.14$16,098$619.52+$13.9KHGITX
8$34,414$2,275.37$17,295$681.69+$17.1KHGITX
9$39,259$2,436.46$18,599$750.82+$20.7KHGITX
10$44,605$2,597.67$20,022$827.78+$24.6KHGITX

HGITX vs JNJ: Complete Analysis 2026

HGITXStock

Under normal circumstances, the fund invests at least 80% of its assets in common stocks. Its portfolio seeks to be broadly diversified by industry and company. The fund may invest in a broad range of market capitalizations, but the advisor tends to focus on large capitalization companies with market capitalizations similar to those of companies in the S&P 500 Index.

Full HGITX Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this HGITX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HGITX vs SCHDHGITX vs JEPIHGITX vs OHGITX vs KOHGITX vs MAINHGITX vs ABBVHGITX vs MRKHGITX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.